drug
Fluarix
Marketedupdated 3mo agoby GlaxoSmithKline Consumer Healthcare LP
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying Fluarix
- phase3Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants
- phase3Immunogenicity Trial of 3 Influenza Vaccines
- phase3A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
- phase4A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India
- phase2A Study to Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Based Vaccine Encoding for the Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF), With and Without Co-administration, in Adults Aged 60 Years and Older in Stable Health
- phase3A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
- phase2Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers.
- phase3A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that